(Q38799823)

6 September 2017

title

Lifestyle and Dietary Interventions in the Management of Nonalcoholic Fatty Liver Disease (English)

1 reference

metabolic dysfunction–associated steatotic liver disease

6 September 2017

main subject

1 reference

William N Hannah

1

1 reference

6 September 2017

Stephen A Harrison

series ordinal

2

1 reference

6 September 2017

publication date

6 April 2016

1 reference

Digestive Diseases and Sciences

6 September 2017

published in

1 reference

6 September 2017

volume

61

1 reference

6 September 2017

issue

5

1 reference

6 September 2017

page(s)

1365-1374

1 reference

The role of diet and nutritional intervention for the management of patients with NAFLD.

6 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4153-Y

Histopathological stages of nonalcoholic fatty liver disease in type 2 diabetes: prevalences and correlated factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4153-Y

Prevalence of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis Among a Largely Middle-Aged Population Utilizing Ultrasound and Liver Biopsy: A Prospective Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4153-Y

Predictors of all-cause mortality and liver-related mortality in patients with non-alcoholic fatty liver disease (NAFLD).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4153-Y

Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4153-Y

Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4153-Y

Orlistat for overweight subjects with nonalcoholic steatohepatitis: A randomized, prospective trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4153-Y

Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4153-Y

Weight Loss Through Lifestyle Modification Significantly Reduces Features of Nonalcoholic Steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4153-Y

Impact of current treatments on liver disease, glucose metabolism and cardiovascular risk in non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis of randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4153-Y

Total body weight loss of ≥ 10 % is associated with improved hepatic fibrosis in patients with nonalcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4153-Y

The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4153-Y

6. Obesity Management for the Treatment of Type 2 Diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4153-Y

Role of diet and nutritional management in non-alcoholic fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4153-Y

One-year intense nutritional counseling results in histological improvement in patients with non-alcoholic steatohepatitis: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4153-Y

Effect on Hepatic Morphology of Treatment of Obesity by Fasting, Reducing Diets and Small-Bowel Bypass

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4153-Y

Randomized comparison of reduced fat and reduced carbohydrate hypocaloric diets on intrahepatic fat in overweight and obese human subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4153-Y

The effect of a low-carbohydrate, ketogenic diet on nonalcoholic fatty liver disease: a pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4153-Y

RETRACTED: Primary Prevention of Cardiovascular Disease with a Mediterranean Diet

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4153-Y

A low carbohydrate Mediterranean diet improves cardiovascular risk factors and diabetes control among overweight patients with type 2 diabetes mellitus: a 1-year prospective randomized intervention study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4153-Y

Lifestyle behaviors associated with lower risk of having the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4153-Y

Metabolic syndrome is associated with greater histologic severity, higher carbohydrate, and lower fat diet in patients with NAFLD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4153-Y

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4153-Y

Physical activity recommendations, exercise intensity, and histological severity of nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4153-Y

Exercise and non-alcoholic fatty liver disease: a systematic review and meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4153-Y

Prospective histopathologic evaluation of lifestyle modification in nonalcoholic fatty liver disease: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4153-Y

Resistance exercise reduces liver fat and its mediators in non-alcoholic fatty liver disease independent of weight loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4153-Y

Effect of resistance training on non-alcoholic fatty-liver disease a randomized-clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4153-Y

Long-term effectiveness of diet-plus-exercise interventions vs. diet-only interventions for weight loss: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4153-Y

Clinical trial: a nutritional supplement Viusid, in combination with diet and exercise, in patients with nonalcoholic fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4153-Y

Therapeutic effects of restricted diet and exercise in obese patients with fatty liver.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4153-Y

Interactions between the intestinal microbiome and liver diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4153-Y

Nutritional Modulation of Non-Alcoholic Fatty Liver Disease and Insulin Resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4153-Y

Nutritional assessment and hepatic fatty acid composition in non-alcoholic fatty liver disease (NAFLD): a cross-sectional study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4153-Y

Liver fat is reduced by an isoenergetic MUFA diet in a controlled randomized study in type 2 diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4153-Y

The Mediterranean diet improves hepatic steatosis and insulin sensitivity in individuals with non-alcoholic fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4153-Y

Increase in long-chain polyunsaturated fatty acid n - 6/n - 3 ratio in relation to hepatic steatosis in patients with non-alcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4153-Y

Omega-3 supplementation and non-alcoholic fatty liver disease: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4153-Y

Double-blind randomized placebo-controlled clinical trial of omega 3 fatty acids for the treatment of diabetic patients with nonalcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4153-Y

Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4153-Y

Metabolic effects of fructose and the worldwide increase in obesity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4153-Y

Increased fructose consumption is associated with fibrosis severity in patients with nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4153-Y

Fructose, high-fructose corn syrup, sucrose, and nonalcoholic fatty liver disease or indexes of liver health: a systematic review and meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4153-Y

Higher fructose intake is inversely associated with risk of nonalcoholic fatty liver disease in older Finnish adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4153-Y

Effect of vitamin E or metformin for treatment of nonalcoholic fatty liver disease in children and adolescents: the TONIC randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4153-Y

Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4153-Y

Lifestyle intervention and antioxidant therapy in children with nonalcoholic fatty liver disease: a randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4153-Y

Coffee, caffeine, and the risk of liver cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4153-Y

Coffee consumption and reduced risk of hepatocellular carcinoma: findings from the Singapore Chinese Health Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4153-Y

Coffee consumption and NAFLD: a community based study on 1223 subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4153-Y

Coffee consumption and nonalcoholic fatty liver onset: a prospective study in the general population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4153-Y

Protective role of coffee in non-alcoholic fatty liver disease (NAFLD).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4153-Y

Role of the Gut Microbiome in Nonalcoholic Fatty Liver Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4153-Y

Randomised clinical trial: The beneficial effects of VSL#3 in obese children with non-alcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4153-Y

Synbiotic supplementation in nonalcoholic fatty liver disease: a randomized, double-blind, placebo-controlled pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4153-Y

Association of Coffee Consumption With Overall and Cause-Specific Mortality in a Large US Prospective Cohort Study.

21 January 2018

1 reference

12 December 2020

Treatment of nonalcoholic steatohepatitis with probiotics. A proof-of-concept study

1 reference

12 December 2020

Sedentary lifestyle and antecedents of cardiovascular disease in young adults

1 reference

12 December 2020

Association of coffee and caffeine consumption with fatty liver disease, nonalcoholic steatohepatitis, and degree of hepatic fibrosis

1 reference

12 December 2020

Effect of two different hypocaloric diets in transaminases and insulin resistance in nonalcoholic fatty liver disease and obese patients.

1 reference

12 December 2020

Adherence to the Mediterranean diet is associated with the severity of non-alcoholic fatty liver disease

1 reference

12 December 2020

Nonalcoholic steatosis and steatohepatitis. I. Molecular mechanism for polyunsaturated fatty acid regulation of gene transcription

1 reference

12 December 2020

Role of leisure-time physical activity in nonalcoholic fatty liver disease: a population-based study

1 reference

12 December 2020

Screening diabetic patients for non-alcoholic fatty liver disease with controlled attenuation parameter and liver stiffness measurements: a prospective cohort study

1 reference

12 December 2020

Dietary fructose consumption among US children and adults: the Third National Health and Nutrition Examination Survey

1 reference

12 December 2020

Carbohydrate intake and nonalcoholic fatty liver disease: fructose as a weapon of mass destruction

1 reference

12 December 2020

High coffee intake is associated with lower grade nonalcoholic fatty liver disease: the role of peripheral antioxidant activity.

1 reference

12 December 2020

Vitamin E and vitamin C treatment improves fibrosis in patients with nonalcoholic steatohepatitis

1 reference

12 December 2020

Association of cardiorespiratory fitness, body mass index, and waist circumference to nonalcoholic fatty liver disease

1 reference

12 December 2020

n-3 polyunsaturated fatty acids, inflammation, and inflammatory diseases

1 reference

12 December 2020

Independent effects of physical activity in patients with nonalcoholic fatty liver disease

1 reference

12 December 2020

Omega-3 polyunsaturated fatty acids in treating non-alcoholic steatohepatitis: A randomized, double-blind, placebo-controlled trial

1 reference

12 December 2020

Effects of a low-fat diet compared with those of a high-monounsaturated fat diet on body weight, plasma lipids and lipoproteins, and glycemic control in type 2 diabetes

1 reference

12 December 2020

10.1007/S10620-016-4153-Y

Identifiers

DOI

1 reference

Dimensions Publication ID

6 September 2017

1017866665

0 references

1 reference